ENTITY
Kintor Pharmaceutical

Kintor Pharmaceutical (9939 HK)

70
Analysis
Health CareChina
Kintor Pharmaceutical Limited develops and markets drugs. The Company produces and sells androgen receptor antagonists, small molecule innovative drugs, and other products. Kintor Pharmaceutical markets its products primarily throughout China with limited overseas.
more
28 Jul 2021 08:55

Pre-IPO Yonghe Medical Group - Here Are the Concerns

The article analyzed Yonghe Medical Group in terms of the concerns and challenges that deserve investors’ attention,including the business...

Logo
390 Views
Share
22 Jun 2021 12:35

HSCI Index Rebalance & Stock Connect: Expected Changes in September

Currently we see 28 potential inclusions & 22 deletions from the HSCI at the Sep rebalance. Most of the inclusions will join Stock Connect while...

Logo
672 Views
Share
17 Jun 2021 09:16

Industry Report - Insights on Hair Loss Prevention and Hair Growth Industry

This article analyzed China hair loss prevention and hair growth industry in terms of the market potential, the hair loss drugs, the hair...

Logo
349 Views
Share
26 May 2021 18:43

Kintor Pharma (开拓药业) Placement - Still Riding the COVID Momentum

Kintor Pharmaceutical (9939 HK) is looking to raise up to a total of US$183m in its concurrent top-up and secondary placement.

Share
bullishYidu Tech Inc
18 May 2021 10:26

HSCI Index Rebalance and Stock Connect: Potential Changes in June and September

A look at the potential changes to the HSCI at the June & September reviews and stocks that could be included in/excluded from Stock Connect. These...

Logo
655 Views
Share
x